James Posada, Ph.D., MBA, is founder and Chief Executive Officer…
James Posada, PH.D., MBA
Founder and Chief Executive Officer
James Posada, Ph.D., MBA, is founder and Chief Executive Officer of Resolve Therapeutics. Previously, James was Chief Business Officer of GlycoFi, where he designed the business strategy and executed partnerships, including the 2006 sale of the company to Merck. James is a scientist who has made important contributions to the field of signal transduction, including the identification and cloning of the first full length MAP kinase ERK2, and identifying the upstream activating kinase MEK. Following his postdoctoral training with Jonathan Cooper, he was a faculty member at the University of Vermont School of Medicine where he built an NIH-funded basic research group. From academics, James pivoted into drug discovery, joining Eli Lilly where he led multiple research groups as a member of the biotherapeutics management team.